James N. Topper, Director at LA JOLLA PHARMACEUTICAL CO (LJPC), sold 5,872,711 shares at $0.06 ($369K) on 2009-02-25, disclosed to the SEC on 2009-02-26.
Open-market sale of $369k LJPC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.07 | 1,662,000 | $116K | 31.5% |
| 2 | $0.06 | 1,454,000 | $87K | 23.6% |
| 3 | $0.06 | 2,756,711 | $165K | 44.8% |
| Total | $0.06 avg | 5,872,711 | $369K | 100% |
| Filing → |
| NAMS | BUY | 2025-08-13 | $11K | — | Filing → |
| NAMS | BUY | 2025-06-26 | $69K | — | Filing → |
| NAMS | BUY | 2025-06-18 | $167K | — | Filing → |